D.E. Shaw & Co
AVNS icon

D.E. Shaw & Co’s Avanos Medical AVNS Stock Holding History

D.E. Shaw & Co’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-6,288
Closed -$210K – 3404
2015
Q4 		$210K Sell
6,288
-1,332
-17% -$41.4K ﹤0.01% 3539
2015
Q3 		$217K Hold
7,620
– – ﹤0.01% 3472
2015
Q2 		$309K Hold
7,620
– – ﹤0.01% 3400
2015
Q1 		$375K Hold
7,620
– – ﹤0.01% 3207
2014
Q4 		$346K Buy
+7,620
New +$299K ﹤0.01% 3563

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

D.E. Shaw & Co's AVNS Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Avanos Medical (AVNS) stake by 45% in Q1 2026, selling an estimated $7.26M and leaving 671,413 shares worth $9.41M. The position accounts for 0.01% of the portfolio, ranked #1697.

D.E. Shaw & Co first reported a position in AVNS in Q4 2014 and has held it in 46 quarters since. The position peaked at $30.1M in Q1 2022. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • D.E. Shaw & Co held 671,413 shares of Avanos Medical worth $9.41M as of Q1 2026.
  • D.E. Shaw & Co sold 539,043 Avanos Medical shares in Q1 2026, an estimated $7.26M.
  • Avanos Medical made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1697 holding.
  • D.E. Shaw & Co first reported a position in Avanos Medical in Q4 2014 and has held it in 46 quarters since.
  • D.E. Shaw & Co's Avanos Medical position peaked at $30.1M in Q1 2022.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.